Press Release Archive - Business Development News

Business Development News

05.09.2013
Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure
11.14.2012
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer’s Disease
10.22.2012
Forest Laboratories and moksha8 Form Broad Strategic Alliance for Latin America
10.01.2012
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Second Quarter Earnings
09.27.2012
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
06.01.2012
Forest Laboratories and Nabriva Therapeutics Sign Agreement
04.02.2012
Forest Laboratories, Inc. Announces Buyout of Bystolic Royalties from Janssen Pharmaceutica NV
04.19.2011
Forest Laboratories and Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythmic Agent
04.13.2011
Forest Laboratories Completes Acquisition of Clinical Data, Inc.
04.12.2011
Forest Laboratories Announces Successful Completion of Tender Offer for Securities of Clinical Data, Inc.